The European biotechnology R&D enterprises landscape in 2023 shows Italy leading, followed by Spain and the UK. The Netherlands displayed strong growth, while Germany slightly declined. Lithuania showed remarkable growth with the highest year-on-year increase. Despite variations, the sector overall reflects growth across most countries, with significant contributions from established players and emerging markets.
Future trends to watch include potential technological advancements and regulatory developments influencing market dynamics. It’s crucial to monitor how emerging technologies and international collaborations might drive growth, particularly in smaller markets with high growth rates and those showing potential for expansion. Additionally, investment trends will play a significant role in shaping the industry's trajectory across Europe.
Top countries in Number of Enterprises of Biotechnology Research and Experimental Development by Country
| # | 10 Countries | Units (Enterprises) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 5,900 | 2023 | +5.5% | +7.74% | View data |
| 2 | 2 Spain | 2,070 | 2023 | +6.04% | +9.09% | View data |
| 3 | 3 United Kingdom | 1,270 | 2023 | +4.1% | +4.34% | View data |
| 4 | 4 Netherlands | 1,160 | 2023 | +9.05% | +11.95% | View data |
| 5 | 5 France | 1,090 | 2023 | +0.46% | +1.88% | View data |
| 6 | 6 Germany | 868 | 2023 | +2% | -0.21% | View data |
| 7 | 7 Belgium | 579 | 2023 | +14.2% | +7.46% | View data |
| 8 | 8 Sweden | 525 | 2023 | +1.74% | +3.69% | View data |
| 9 | 9 Poland | 391 | 2023 | +5.08% | +4.79% | View data |
| 10 | 10 Hungary | 341 | 2023 | +0.59% | +0.72% | View data |
